Bruno Brochet

18PUBLICATIONS
76CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Semi- and unsupervised learningMemory and attentionMedical virologyElectronic device and system performance evaluation, testing and simulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 10, 2026
Summary of Research: Cognition and Employment Status of People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-Year CLARIFY-MS Study.

|Jun 01, 2026
Correction: Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two‑year Phase IV CLARIFY‑MS Study.

|Mar 10, 2026
Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-year Phase IV CLARIFY-MS Study.

Bruno Brochet, Dawn Langdon, Eva Kubala Havrdova

|Dec 03, 2024
Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis: The Phase IIIb ENSEMBLE 4-Year, Single-Arm, Open-Label Trial.

Hans-Peter Hartung, Ralph H B Benedict, Thomas Berger

|Nov 08, 2024
Sensor-Derived Measures of Motor and Cognitive Functions in People With Multiple Sclerosis Using Unsupervised Smartphone-Based Assessments: Proof-of-Concept Study.

Matthew Scaramozza, Aurélie Ruet, Patrizia A Chiesa

|Jun 24, 2024
Konectom™ cognitive processing speed test enables reliable remote, unsupervised cognitive assessment in people with multiple sclerosis: Exploring the use of substitution time as a novel digital outcome measure.

Matthew Scaramozza, Patrizia A Chiesa, Lauren Zajac

Pageof 3

Frequent Collaborators

6 joint publications

Aurélie Ruet

4 joint publications

Francesco Patti

3 joint publications

Fredrik Piehl

3 joint publications

Alessandra Solari